Nov Inc (NOV)

$13.08 -0.14 (-1.06%)
Market Cap 4.97B
Revenue (ttm) 8.87B
Net Income (ttm) 635.00M
EPS (ttm) N/A
PE Ratio 9.01
Forward PE 11.63
Profit Margin 7.16%
Debt to Equity Ratio 0.27
Volume 4,317,000
Avg Vol 3,916,806
Day's Range N/A - N/A
Shares Out 375.74M
Stochastic %K 9%
Beta 1.28
Analysts Sell
Price Target $16.60

Company Profile

NOV Inc. designs, constructs, manufactures, and sells systems, components, and products for oil and gas drilling and production, and industrial and renewable energy sectors in the United States and internationally. It operates through two segments, Energy Equipment, and Energy Products and Services. The company provides solids control and waste management equipment and services, managed pressure drilling, drilling fluids, premium drillpipe, wired pipe, drilling optimization services, tubular ins...

Industry: Oil & Gas Equipment & Services
Sector: Energy
Phone: 346 223 3000
Website: www.nov.com
Address:
10353 Richmond Avenue, Houston, United States
CHR15M
CHR15M Jun. 24 at 12:21 PM
$HIMS $NOV the truth likely lies somewhere in the middle
0 · Reply
CHR15M
CHR15M Jun. 24 at 12:17 PM
$HIMS CEOs Response to $NOV actions
0 · Reply
myman1956
myman1956 Jun. 24 at 5:09 AM
$HIMS The CEO has been lying saying $NOV is misleading which the facts are that $NOV doesn't need $HIMS in any shape. That downgrades to $15.00 is the reason why so many last week sold at highs that $NOV let the cat out of the bag last week saying cancel all deals last week. That men doesn't even like the hair products that doesn't work is another product that doesn't work.
2 · Reply
AMUNRATHEBLACKGOD
AMUNRATHEBLACKGOD Jun. 23 at 12:43 PM
$HIMS $NOV said it is ”concern” about glp-1 knocks put users at risk…..so what happens when it comes off patent?!….. 5-10% of $HIMS revenues is glp-1s
0 · Reply
ZacksResearch
ZacksResearch Jun. 23 at 12:34 PM
$NOV down 24% over the past year — time to hold or fold? ⚠️ The drop tracks mounting pressures from tariffs, soft demand, and rising corporate costs. Full risk/reward breakdown here 👉 https://www.zacks.com/stock/news/2534898/nov-stock-down-24-in-a-year-should-investors-hold-or-move-on?cid=sm-stocktwits-2-2534898-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2534898_TEASER
0 · Reply
ZacksResearch
ZacksResearch Jun. 23 at 11:35 AM
Is $NOV facing a structural challenge or just a temporary setback? 🤔 The Zacks Rank #5 stock missed Q1 earnings estimates, with adjusted EPS at 19 cents vs. the expected 25 cents. Margin challenges in the Energy Equipment division, declining net income due to higher costs, and macroeconomic risks are adding pressure. 📉 Discover whether NOV is a hold or a sell 👉 https://www.zacks.com/commentary/2534898/nov-stock-down-24-in-a-year-should-investors-hold-or-move-on?cid=sm-stocktwits-2-2534898-body&ADID=SYND_STOCKTWITS_TWEET_2_2534898_BODY
0 · Reply
Mpete
Mpete Jun. 16 at 6:13 PM
$NOV Nice blessing with that Divvy. How do you know when those are coming? I had no idea
0 · Reply
Dsharky
Dsharky Jun. 16 at 1:41 PM
$NOV looks like the special dividend didn't qualify for DRIP?
1 · Reply
Traderatodds
Traderatodds Jun. 14 at 6:54 PM
$NOV did anyone in here work at the anaehim/orange plant?
0 · Reply
JarvisFlow
JarvisFlow Jun. 5 at 1:00 PM
Wells Fargo has updated their rating for NOV ( $NOV ) to Underweight with a price target of 10.
1 · Reply
Latest News on NOV
NOV Declares Regular Quarterly Dividend and Supplemental Dividend

May 21, 2025, 6:30 AM EDT - 5 weeks ago

NOV Declares Regular Quarterly Dividend and Supplemental Dividend

NOV Inc. (NOV) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 12:44 PM EDT - 2 months ago

NOV Inc. (NOV) Q1 2025 Earnings Call Transcript

NOV Reports First Quarter 2025 Results

Apr 28, 2025, 5:45 PM EDT - 2 months ago

NOV Reports First Quarter 2025 Results

NOV Announces Key Leadership Changes

Mar 19, 2025, 5:00 PM EDT - 3 months ago

NOV Announces Key Leadership Changes

NOV Declares Regular Quarterly Dividend

Feb 21, 2025, 6:30 AM EST - 4 months ago

NOV Declares Regular Quarterly Dividend

NOV: Shareholder Returns Have Likely Peaked For Now

Feb 7, 2025, 3:21 PM EST - 4 months ago

NOV: Shareholder Returns Have Likely Peaked For Now

NOV Inc. (NOV) Q4 2024 Earnings Call Transcript

Feb 5, 2025, 3:12 PM EST - 4 months ago

NOV Inc. (NOV) Q4 2024 Earnings Call Transcript

NOV Reports Fourth Quarter and Full-Year 2024 Earnings

Feb 4, 2025, 5:45 PM EST - 5 months ago

NOV Reports Fourth Quarter and Full-Year 2024 Earnings

NOV Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

Dec 23, 2024, 6:30 AM EST - 6 months ago

NOV Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

NOV Appoints Chris Kendall to the Board of Directors

Dec 16, 2024, 6:30 AM EST - 6 months ago

NOV Appoints Chris Kendall to the Board of Directors

The Big 3: DJT, JD, NOV

Dec 5, 2024, 12:27 PM EST - 7 months ago

The Big 3: DJT, JD, NOV

DJT JD

Venture Builder VC Launches NOV Supernova Accelerator to Drive Digital Transformation in Upstream Oil & Gas with Disruptive Startups

Nov 12, 2024, 2:11 PM EST - 8 months ago

Venture Builder VC Launches NOV Supernova Accelerator to Drive Digital Transformation in Upstream Oil & Gas with Disruptive Startups

These Analysts Lower Their Forecasts On NOV Following Q3 Results

Oct 28, 2024, 11:06 AM EDT - 8 months ago

These Analysts Lower Their Forecasts On NOV Following Q3 Results

NOV Inc. (NOV) Q3 2024 Earnings Call Transcript

Oct 25, 2024, 2:55 PM EDT - 8 months ago

NOV Inc. (NOV) Q3 2024 Earnings Call Transcript

NOV Reports Third Quarter 2024 Results

Oct 24, 2024, 5:45 PM EDT - 8 months ago

NOV Reports Third Quarter 2024 Results

14 energy stocks whose ample cash flow might benefit shareholders

Sep 30, 2024, 11:11 AM EDT - 9 months ago

14 energy stocks whose ample cash flow might benefit shareholders

BTU CHRD COP DVN FANG HAL LBRT

NOV Announces Third Quarter 2024 Earnings Conference Call

Sep 23, 2024, 6:30 AM EDT - 9 months ago

NOV Announces Third Quarter 2024 Earnings Conference Call

NOV Inc. (NOV) Q2 2024 Earnings Call Transcript

Jul 26, 2024, 3:27 PM EDT - 11 months ago

NOV Inc. (NOV) Q2 2024 Earnings Call Transcript

NOV Reports Second Quarter 2024 Results

Jul 25, 2024, 6:00 PM EDT - 11 months ago

NOV Reports Second Quarter 2024 Results

6 Stocks That Have Come Too Far, Too Fast

Jul 22, 2024, 11:23 AM EDT - 1 year ago

6 Stocks That Have Come Too Far, Too Fast

BJRI COOP CUBI MXL SAH

NOV: A Top Oil And Gas Services Pick Under Quiet Accumulation

Jul 9, 2024, 5:28 PM EDT - 1 year ago

NOV: A Top Oil And Gas Services Pick Under Quiet Accumulation

NOV Announces Second Quarter 2024 Earnings Conference Call

Jun 21, 2024, 6:30 AM EDT - 1 year ago

NOV Announces Second Quarter 2024 Earnings Conference Call

NOV Announces 50 Percent Increase in Regular Quarterly Dividend

May 16, 2024, 6:30 AM EDT - 1 year ago

NOV Announces 50 Percent Increase in Regular Quarterly Dividend

NOV Inc. (NOV) Q1 2024 Earnings Call Transcript

Apr 26, 2024, 3:50 PM EDT - 1 year ago

NOV Inc. (NOV) Q1 2024 Earnings Call Transcript

NOV Reports First Quarter 2024 Results, Return of Capital Framework, $1 Billion Share Repurchase Authorization, and Plan to Increase Dividend 50%

Apr 25, 2024, 6:09 PM EDT - 1 year ago

NOV Reports First Quarter 2024 Results, Return of Capital Framework, $1 Billion Share Repurchase Authorization, and Plan to Increase Dividend 50%

Bullish on NOV

Apr 15, 2024, 1:14 PM EDT - 1 year ago

Bullish on NOV

Arcosa, Inc. Announces Completion of Ameron Acquisition

Apr 9, 2024, 4:15 PM EDT - 1 year ago

Arcosa, Inc. Announces Completion of Ameron Acquisition

ACA

NOV Announces First Quarter 2024 Earnings Conference Call

Mar 26, 2024, 6:30 AM EDT - 1 year ago

NOV Announces First Quarter 2024 Earnings Conference Call

Arcosa Announces Agreement to Acquire Ameron Pole Products from NOV Inc.

Mar 11, 2024, 8:00 AM EDT - 1 year ago

Arcosa Announces Agreement to Acquire Ameron Pole Products from NOV Inc.

ACA

NOV Announces Opening of Regional Headquarters in Dammam, Saudi Arabia

Feb 22, 2024, 4:34 PM EST - 1 year ago

NOV Announces Opening of Regional Headquarters in Dammam, Saudi Arabia

NOV Inc. (NOV) Q4 2023 Earnings Call Transcript

Feb 2, 2024, 1:58 PM EST - 1 year ago

NOV Inc. (NOV) Q4 2023 Earnings Call Transcript

NOV Reports Fourth Quarter and Full Year 2023 Earnings

Feb 1, 2024, 5:30 PM EST - 1 year ago

NOV Reports Fourth Quarter and Full Year 2023 Earnings

NOV Inc. (NOV) Q3 2023 Earnings Call Transcript

Oct 27, 2023, 12:37 PM EDT - 1 year ago

NOV Inc. (NOV) Q3 2023 Earnings Call Transcript

NOV Reports Third Quarter 2023 Earnings

Oct 26, 2023, 5:00 PM EDT - 1 year ago

NOV Reports Third Quarter 2023 Earnings

NOV Announces Third Quarter 2023 Earnings Conference Call

Sep 12, 2023, 11:48 AM EDT - 1 year ago

NOV Announces Third Quarter 2023 Earnings Conference Call

Selling Time? Oil, Inflation, Debt Concerns And A T-Bill Portfolio

Aug 15, 2023, 11:00 AM EDT - 2 years ago

Selling Time? Oil, Inflation, Debt Concerns And A T-Bill Portfolio

BBSA BIL BILS DIA EDV EGF EWJ

NOV Inc. (NOV) Q2 2023 Earnings Call Transcript

Jul 27, 2023, 3:44 PM EDT - 2 years ago

NOV Inc. (NOV) Q2 2023 Earnings Call Transcript

NOV Reports Second Quarter 2023 Earnings

Jul 26, 2023, 5:00 PM EDT - 2 years ago

NOV Reports Second Quarter 2023 Earnings

NOV Announces Second Quarter 2023 Earnings Conference Call

Jun 13, 2023, 6:00 PM EDT - 2 years ago

NOV Announces Second Quarter 2023 Earnings Conference Call

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against NOV Inc. and Encourages Investors with Losses to Contact the Firm

May 3, 2023, 9:30 AM EDT - 2 years ago

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against NOV Inc. and Encourages Investors with Losses to Contact the Firm

NOV Inc. (NOV) Q1 2023 Earnings Call Transcript

Apr 27, 2023, 4:20 PM EDT - 2 years ago

NOV Inc. (NOV) Q1 2023 Earnings Call Transcript

NOV Reports First Quarter 2023 Earnings

Apr 26, 2023, 5:00 PM EDT - 2 years ago

NOV Reports First Quarter 2023 Earnings

NOV: 2023 Off To A Bad Start

Mar 27, 2023, 5:43 PM EDT - 2 years ago

NOV: 2023 Off To A Bad Start

NOV: Shares Still A Value Ahead Of Earnings, At A Key Spot Technically

Mar 27, 2023, 11:36 AM EDT - 2 years ago

NOV: Shares Still A Value Ahead Of Earnings, At A Key Spot Technically

NOV Announces First Quarter 2023 Earnings Conference Call

Mar 10, 2023, 4:02 PM EST - 2 years ago

NOV Announces First Quarter 2023 Earnings Conference Call

NOV Inc. (NOV) Q4 2022 Earnings Call Transcript

Feb 7, 2023, 3:38 PM EST - 2 years ago

NOV Inc. (NOV) Q4 2022 Earnings Call Transcript

NOV Reports Fourth Quarter and Full Year 2022 Results

Feb 6, 2023, 5:00 PM EST - 2 years ago

NOV Reports Fourth Quarter and Full Year 2022 Results

VDY: O Canada! How Your Dividends Tempt Me So!

Dec 30, 2022, 7:03 AM EST - 2 years ago

VDY: O Canada! How Your Dividends Tempt Me So!

AMZA BMO CNQ ENB EWJ FXC GDXD

NOV Announces Fourth Quarter and Full Year 2022 Earnings Conference Call

Dec 2, 2022, 4:00 PM EST - 2 years ago

NOV Announces Fourth Quarter and Full Year 2022 Earnings Conference Call

CHR15M
CHR15M Jun. 24 at 12:21 PM
$HIMS $NOV the truth likely lies somewhere in the middle
0 · Reply
CHR15M
CHR15M Jun. 24 at 12:17 PM
$HIMS CEOs Response to $NOV actions
0 · Reply
myman1956
myman1956 Jun. 24 at 5:09 AM
$HIMS The CEO has been lying saying $NOV is misleading which the facts are that $NOV doesn't need $HIMS in any shape. That downgrades to $15.00 is the reason why so many last week sold at highs that $NOV let the cat out of the bag last week saying cancel all deals last week. That men doesn't even like the hair products that doesn't work is another product that doesn't work.
2 · Reply
AMUNRATHEBLACKGOD
AMUNRATHEBLACKGOD Jun. 23 at 12:43 PM
$HIMS $NOV said it is ”concern” about glp-1 knocks put users at risk…..so what happens when it comes off patent?!….. 5-10% of $HIMS revenues is glp-1s
0 · Reply
ZacksResearch
ZacksResearch Jun. 23 at 12:34 PM
$NOV down 24% over the past year — time to hold or fold? ⚠️ The drop tracks mounting pressures from tariffs, soft demand, and rising corporate costs. Full risk/reward breakdown here 👉 https://www.zacks.com/stock/news/2534898/nov-stock-down-24-in-a-year-should-investors-hold-or-move-on?cid=sm-stocktwits-2-2534898-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2534898_TEASER
0 · Reply
ZacksResearch
ZacksResearch Jun. 23 at 11:35 AM
Is $NOV facing a structural challenge or just a temporary setback? 🤔 The Zacks Rank #5 stock missed Q1 earnings estimates, with adjusted EPS at 19 cents vs. the expected 25 cents. Margin challenges in the Energy Equipment division, declining net income due to higher costs, and macroeconomic risks are adding pressure. 📉 Discover whether NOV is a hold or a sell 👉 https://www.zacks.com/commentary/2534898/nov-stock-down-24-in-a-year-should-investors-hold-or-move-on?cid=sm-stocktwits-2-2534898-body&ADID=SYND_STOCKTWITS_TWEET_2_2534898_BODY
0 · Reply
Mpete
Mpete Jun. 16 at 6:13 PM
$NOV Nice blessing with that Divvy. How do you know when those are coming? I had no idea
0 · Reply
Dsharky
Dsharky Jun. 16 at 1:41 PM
$NOV looks like the special dividend didn't qualify for DRIP?
1 · Reply
Traderatodds
Traderatodds Jun. 14 at 6:54 PM
$NOV did anyone in here work at the anaehim/orange plant?
0 · Reply
JarvisFlow
JarvisFlow Jun. 5 at 1:00 PM
Wells Fargo has updated their rating for NOV ( $NOV ) to Underweight with a price target of 10.
1 · Reply
WallStreetPro2021
WallStreetPro2021 May. 31 at 10:18 PM
$NOG $EPM $NOV $COP Piper Sandler issues a $11.00 price target on PROP – Prairie Operating, trading at $3.87 a share. Upstream producer Prairie Operating Company (PROP), lots of insider buys in the last two weeks as their acquisition on Bayswater completed and significant production was added. They are well hedged at $68.27 a barrel for 2025 and from Q1 2026 thru Q1 2028 at $64.29 a barrel. Piper Sandler issues a $11.00 price target, trading at $3.87 a share. https://www.investing.com/news/analyst-ratings/piper-sandler-sets-11-target-for-prairie-operating-stock-93CH-4011820 Actual Piper Sandler 31- page analysis attached https://storage.googleapis.com/vendorgroup-assets/site/4308a1c5-ae18-4626-847f-4861aa44b367/2025/04/30/681255b42f7fb57b7c7e7cd2/Piper-Sandler-4.30.25.pdf
0 · Reply
Mpete
Mpete May. 28 at 10:58 AM
$NOV It's amazing that no one seems to understand that this is an oil drilling company, NOT the pharma company.
2 · Reply
OnlyTimeWillTell888
OnlyTimeWillTell888 May. 15 at 4:16 PM
$SEPN I wonder why $NOV didn’t just buy SEPN? Unless it was completely off the table which is why they struck the partnership deal.
2 · Reply
BiDirDelta
BiDirDelta May. 13 at 1:14 PM
$NOV $LLY $HIMS
0 · Reply
BiDirDelta
BiDirDelta May. 12 at 6:24 PM
$NOV $LLY $HIMS Global Drug Price Economics: Who does pharma sell there poison pills & shots to? 1) All Foreign Govts Excluding the USA Negotiate & buy drugs Directly from pharma. One large Govt. buyer gets a better deal 2) In the USA, the PBM's & Insurance Cos. Negotiate drug prices & purchase them, thus the middle man greed is the reason for higher drug prices in the USA. 3) President Trump's New EO on Lower Drug Prices & Favored Nation Status Will Lower drug prices in the USA by leveraging the lowest price that the Best Foreign Govt. Negotiators have secured. Perhaps some Foreign Govts. may have to pay slightly higher prices The Art of the Trump Pharma Drug Deal reads like this, Trump is Leveraging the Very Best Foreign Negotiators to help him get lower prices for the USA. Foreign Govts are Not going to bend over & Negotiate higher drug prices as well as lose drug manufacturing to the USA. Foreign Govts will Negotiate to their death Pharma ends up in price wars across the globe & loses
0 · Reply
UncleStock
UncleStock May. 12 at 10:39 AM
$WHD $HP $NOV $TDW suggested for $OSX US PHLX Oil Service - value screen: https://zpr.io/t58fg
0 · Reply
DrKillinger
DrKillinger May. 1 at 3:21 PM
$NOV CVS’s decision to prioritize $NOV's Wegovy and drop Eli Lily's Zepbound is a significant win for Novo Nordisk, likely increasing Wegovy’s sales by hundreds of millions annually and boosting its U.S. market share by 5–10 percentage points in the near term. this should be going up as LLY goes down today.
1 · Reply
JarvisFlow
JarvisFlow May. 1 at 3:04 PM
Wells Fargo updates rating for NOV ( $NOV ) to Underweight, target set at 10 → 11.
0 · Reply
JarvisFlow
JarvisFlow May. 1 at 2:34 PM
Piper Sandler updates rating for NOV ( $NOV ) to Neutral, target set at 18 → 16.
0 · Reply
JarvisFlow
JarvisFlow Apr. 30 at 10:30 PM
Barclays has adjusted their stance on NOV ( $NOV ), setting the rating to Underweight with a target price of 13 → 11.
0 · Reply
JarvisFlow
JarvisFlow Apr. 30 at 3:46 PM
RBC Capital has updated their rating for NOV ( $NOV ) to Outperform with a price target of 19.
0 · Reply
Jalard
Jalard Apr. 29 at 4:30 PM
$NOV Sudden Dip buyers is a good sign of support.
0 · Reply